Filter
1277
Text search:
Глобальный
Featured
51
45
Language
Document type
425
206
128
115
102
70
67
52
38
19
17
14
13
10
1
Countries / Regions
1270
25
16
16
13
11
10
10
9
9
8
8
7
6
6
5
5
4
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
414
193
84
41
36
20
9
Toolboxes
391
226
148
115
79
67
38
32
22
22
21
18
14
11
10
10
9
4
3
3
2
1
Chronic noncommunicable diseases (NCDs) are the number one cause of death and disability in the world.
The term NCDs refers to a group of conditions that are not mainly caused by an acute infection, result in long-term health consequences and often create a need for long-term treatment and care.
...
Noncommunicable diseases (NCDs) or Chronic noncommunicable diseases (NCDs) are the 1st cause of death and disability worldwide.
The term NCDs refers to a group of conditions that are not mainly caused by an acute infection, result in long-term health consequences and often create a need for long-
...
This book is one of fifteen modules of the “Noncommunicable disease education manual for primary health care professionals and patients”. This manual is intended to provide health information on the prevention and control of hypertension and diabetes. This will be used in the form of a flip char
...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – cause nearly three-quarters of deaths in the world. Their drivers are social, environmental, commercial and genetic, and their presence is g
...
This new course focuses on advocacy and the role it plays in raising awareness of the impact that NCDs have on an individual's quality of life and their surrounding community. Lessons in this course will explore the important role that advocacy has when it comes to engaging in discussions, taking ac
...
WHO Package of Essential NCD interventions will help to improve the coverage of appropriate services for people with NCDs services in primary care settings. The HEARTS technical package provides a strategic approach to improving cardiovascular health in countries in primary care settings.
Readily access selected guidelines, reports and other knowledge resources to enhance evidence-informed, multisectoral, and multistakeholder initiatives in NCD prevention and control – curated by WHO's Global NCD Platform and supported by GCM Participants.
An integrated approach is particularly important for low-resource settings for efficient use of limited resources. The course contents will include risk factors, clinical course, guidance and protocols for diagnosis, management and referral as needed for NCDs in PHC. SEARO NCD PEN-HEARTS is a series
...
The course aims to cover the types of NCDs and risk factors, the challenges of delivering NCD services in primary health care, elements of WHO technical packages (PEN and HEARTS) for NCDs and how to adapt these packages in primary health care.
Psychoactive drugs are substances that, when taken in or administered into one's system, affect mental processes, e.g. perception, consciousness, cognition or mood and emotions. Psychoactive drugs belong to a broader category of psychoactive substances that include also alcohol and nicotine. “Psy
...
The Defeat-NCD Partnership prioritises poorer countries because they bear the brunt of the enormous impact of NCDs with some 48% of premature deaths occurring in low and lower-middle income countries. The resident of a low-income country faces a lifetime chance of 20-30% of dying from an NCD under t
...
Occupational exposures to respirable crystalline silica occur in a variety of
industries and occupations because of its extremely common natural occurrence and the wide uses of materials and products that contain it. At least 1.7 million U.S. workers are potentially exposed to respirable crystallin
...
The Johns Hopkins Medicine webpage on occupational lung diseases provides an overview of lung conditions caused by exposure to harmful substances in the workplace. It explains various types of occupational lung diseases, including asbestosis, silicosis, coal workers' pneumoconiosis, and hypersensiti
...
This paper summarises the past, present and future of asbestos exposure. The future scenarios as to the mesothelioma incidence in countries, where asbestos has been banned, are discussed.
Silicosis is a group of occupational lung diseases caused by breathing in silica dust. It has been described since ancient times, when miners and stonecutters were exposed to dust containing this crystalline mineral.
The "Cystic Fibrosis Fact Sheet" by the National Heart, Lung, and Blood Institute provides an overview of cystic fibrosis (CF), a chronic and often fatal genetic disorder affecting the respiratory and digestive systems. The document outlines the causes, genetic inheritance patterns, and symptoms of
...
The document "Cystic Fibrosis Key Findings 2023 for Care Providers" by the Pennsylvania Department of Health summarizes recent findings and insights related to cystic fibrosis (CF). It highlights key statistics on the prevalence and outcomes of CF, emphasizes best practices for patient care, and pro
...
The Cedars-Sinai webpage on occupational lung diseases provides an overview of various lung conditions caused by exposure to harmful substances in the workplace. It outlines common types of occupational lung diseases, including asbestosis, silicosis, coal workers’ pneumoconiosis, and chemical-rela
...
The South African Cystic Fibrosis Association (SACFA) is a non-profit organization dedicated to supporting individuals with cystic fibrosis (CF) in South Africa. Their website provides comprehensive information about CF, including its causes, symptoms, and treatment options. CF is described as an in
...
The article "Under- and over-diagnosis of COPD: a global perspective" reviews the worldwide variation in the prevalence of chronic obstructive pulmonary disease (COPD) and issues related to its misdiagnosis. It highlights that COPD is under-diagnosed due to factors such as limited access to spiromet
...
